Clinical experience with gentamicin in Japan.
D001660:Biliary Tract Diseases / Q000139:chemically induced; D001806:Blood Urea Nitrogen; D003141:Communicable Diseases / Q000188:drug therapy*; D004755:Enterobacteriaceae / Q000187:drug effects; D005128:Eye Diseases / Q000188:drug therapy; D005839:Gentamicins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006261:Headache / Q000139:chemically induced; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D007239:Infections; D007564:Japan; D007674:Kidney Diseases / Q000139:chemically induced; D007759:Labyrinth Diseases / Q000139:chemically induced; D010033:Otitis Media / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013223:Statistics as Topic; D000637:Transaminases / Q000097:blood; D014552:Urinary Tract Infections / Q000188:drug therapy; D014946:Wound Infection / Q000188:drug therapy
D005839:Gentamicins; D000637:Transaminases